Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TTRXthis companyTurn Therapeutics Inc.	$9.84	-17.13×	11.55×	0×	-15.65×	-98.2%	0.0%	0.0%	0.0%	-68.2%	-94.4%	-5.0%	0.02×	1.59×	0×	0.87×	0.0%	1	7.69	1	D+
AGENAgenus Inc.	$7.55	-923.53×	-0.34×	0.82×	6.84×	-468.1%	29.6%	-18.0%	0.1%	-0.0%	-34.5%	-170.2%	-1.24×	5.34×	-0.37×	0.41×	0.0%	6	-14.32	2	C+
ANIXAnixa Biosciences, Inc.	$3.15	-12.15×	8.84×	0×	-12.1×	-99.1%	0.0%	0.0%	0.0%	-72.1%	-82.7%	-5.4%	0.01×	0.09×	0×	8.08×	0.0%	2	7.94	2	C
CGTXCognition Therapeutics, Inc.	$0.69	-4.22×	2.87×	0×	-2.67×	-14.9%	0.0%	0.0%	0.0%	-68.5%	-136.9%	-25.0%	0.02×	1.56×	-3,676.85×	3.45×	0.0%	1	-0.97	2	C+
GLSIGreenwich LifeSciences, Inc.	$16.47	-14.69×	805.09×	0×	-14.37×	-99.2%	0.0%	0.0%	0.0%	-5480.5%	-5505.9%	-3.5%	0×	0.32×	0×	1.06×	0.0%	1	2.27	1	D+
HURATuHURA Biosciences, Inc.	$1.71	-1.2×	1.73×	0×	-1.14×	-100.8%	0.0%	0.0%	0.0%	-143.6%	-145.7%	-76.4%	0.03×	0.1×	-50.85×	0.78×	0.0%	1	-5.35	2	C
Peer median	—	-12.15×	2.87×	0×	-2.67×	-99.2%	0.0%	0.0%	0.0%	-72.1%	-136.9%	-25.0%	0.01×	0.32×	-0.37×	1.06×	0.0%	1	-0.97	2	—